BeOne files STAR interim report with Shanghai Stock Exchange
BeOne Medicines Ltd. filed its 2026 STAR interim report for the six months ended June 30, 2026, detailing research and development expenses allocated by key products in accordance with PRC GAAP and listing rules.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day